ETHIONAMIDE, 125mg, disp. tab., blister


Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list


Add Kit To Wishlist



Therapeutic Action

Thionamide, bacteriostatic

Ethionamide and prothionamide belong to the same therapeutic group.


Drug-Resistant tuberculosis (DR-TB), in combination with other TB medicines

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The 125 mg dispersible tablet is intended for paediatric use. To be dispersed in 10 ml water.

Must be taken with food and/or at bedtime to limit gastrointestinal disturbances.

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.

The quantity to be ordered is calculated per tablet, not per blister.

Precautions for Use

Do not administer to patients with severe hepatic impairment..

May cause gastrointestinal disturbances.

Contraindicated during pregnancy.


Below 25°C - Protect from sunlight